CATALYST PHARMACEUTICALS, INC. 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Nov 5, 2015
Insider Transaction Report
Form 4
Winship M Douglas
V.P. of Regulatory Operations
Transactions
- Exercise/Conversion
Options to purchase common stock
2015-11-04−60,000→ 237,500 totalExercise: $1.09Exp: 2015-11-05→ Common Stock (60,000 underlying) - Exercise/Conversion
Common stock, par value $0.001 per share
2015-11-04$1.09/sh−60,000$65,400→ 134,131 total
Footnotes (1)
- [F1]The option was granted on November 5, 2010 and vested in three equal annual installments.